Huntington's disease: delayed hypersensitivity in vitro to human central nervous system antigens.

Huntington's disease is a hereditary, chronic, degenerative disease of the brain which is transmitted by an autosomal dominant gene. We have discovered that lymphocytes from patients with Huntington's disease respond to the presence of brain tissue from patients with the disease by producing migration inhibition factor, a correlate of the cellular immune response. Lymphocytes from donors without the disease do not respond to the diseased brain tissue, and lymphocytes from patients with Huntington's disease respond only rarely to brain tissue from donors without the disease.

[1]  T. Yoshida,et al.  Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Terry,et al.  STUDIES ON BRAIN BIOPSIES OF PATIENTS WITH HUNTINGTON'S CHOREA , 1974, Journal of neuropathology and experimental neurology.

[3]  R. Feldman,et al.  The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. , 1971, The New England journal of medicine.

[4]  C. Mogensen The glomerular permeability determined by dextran clearance using Sephadex gel filtration. , 1968, Scandinavian journal of clinical and laboratory investigation.